Form 13-F position report

IOVANCE BIOTHERAPEUTICS INC

Reported by CORSAIR CAPITAL MANAGEMENT L P

IOVA CUSIP 462260100 Manager CIK 0001276470

Reported 370,000 shares, unchanged from the prior quarter.

Reported value 256.3%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0.91% This manager · Q3 2026
Shares 370,000 Quarter-end amount reported
Reported value $5,483,400 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-12-31 819000
2026-03-31 1228500
2026-06-30 1539200
2026-09-30 5483400

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for IOVANCE BIOTHERAPEUTICS INC held by CORSAIR CAPITAL MANAGEMENT L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 370,000 0 (0.0%) 0.91% $5,483,400 2026-11-16
Q2 2026 Added 370,000 +20,000 (5.7%) 0.19% $1,539,200 2026-08-14
Q1 2026 Added 350,000 +50,000 (16.7%) 0.18% $1,228,500 2026-05-15
Q4 2025 New 300,000 +300,000 (0.0%) 0.13% $819,000 2026-02-17

Who else reported the position

367 managers reported IOVANCE BIOTHERAPEUTICS INC for Q3 2026.

Managers reporting IOVANCE BIOTHERAPEUTICS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 37,903,960 +946,279 < 0.01% $561,736,688 9 qtrs
MHR FUND MANAGEMENT LLC Unchanged 28,967,103 0 21.06% $429,292,466 16 qtrs
STATE STREET CORPORATION Reduced 21,695,003 -2,783,265 < 0.01% $321,519,944 38 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 18,396,706 +192,458 < 0.01% $272,639,183 3 qtrs
TWO SIGMA INVESTMENTS LP Reduced 14,964,996 -4,045,701 0.16% $221,781,241 10 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 12,279,882 -2,109,117 < 0.01% $181,987,851 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 10,452,242 +127,416 < 0.01% $154,930,479 38 qtrs
D E Shaw & Co Inc Added 9,163,428 +7,020,294 0.06% $135,802,003 28 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 6,238,693 -221,756 0.02% $92,443,267 33 qtrs
The Goldman Sachs Group Inc Reduced 4,937,725 -158,609 < 0.01% $73,177,091 38 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
370,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.